The Pennant Group Inc (PNTG) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
The Pennant Group Inc   (NASDAQ: PNTG)


The Pennant Group Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is The Pennant Group Inc's ROI in the second quarter of 2026?
The Pennant Group Inc achieved a return on average invested assets (ROI) of 4.62 % in its second quarter of 2026, this is above PNTG's average return on investment of 2.87%.
The Pennant Group Inc invested over the 12 months ending in its second quarter of 2026 $832 million

ROI has improved compared to 4.59% in the first quarter of 2026, due to net income growth.

Within the Healthcare sector 113 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1495 to 1614.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 30.77 % 30.13 % 30.38 % 25.37 % 28.18 %
Y / Y Net Income Change TTM 29.51 % 27.81 % 75.12 % 134.64 % 387.2 %
Investment (TTM) in Millions 930 871 863 665 700
Return On Investment (TTM) 4.62 % 4.59 % 4.65 % 4.54 % 4.66 %
PNTG's Overall Ranking # 1614 # 1495 # 1072 # 1320 #
Seq. Investment Change TTM 7.41 % 6.76 % 10.09 % 3.59 % 6.89 %
Seq. Net Income Change TTM 8.21 % 5.25 % 12.85 % 0.77 % 6.79 %
Net Income (TTM) in Millions 38 36 34 30 30

PNTG Company Profile >> Back to PNTG Roi Comparisons >> See Annual PNTG Return On Investment



Return On Investment PNTG's Ranking
Within: No.
Industry # 34
Sector # 114
Overall # 1614

Return On Investment Statistics
High Average Low
4.67 %
2.87 %
-0.6 %
(Mar 31 2025)   (Jun 30 2022)







Financial Statements
The Pennant Group Inc's II. Quarter Investments $ 930 Millions PNTG's Balance sheet
The Pennant Group Inc's II. Quarter Income $ 11 Millions Quarterly PNTG's Income Statement
PNTG's Income by Division See PNTG's Income by Division


PNTG Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 863 597 473 447 463
Y / Y Investment Growth 44.6 % 26.03 % 6 % -3.5 % 9.5 %
Net Income in Millions 34 24 14 7 2
Y / Y Net Income Growth 38.72 % 74.97 % 92.05 % 237.2 % -86.19 %
Annual Return On Investment 3.91 % 4.08 % 2.94 % 1.62 % 0.46 %


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 3.91 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PNTG's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PNTG's Competitors
Subscribers only: Roi for The Pennant Group Inc's Suppliers
Subscribers only: Return On Investment for PNTG's Customers

Other Ratios
PNTG's Roa PNTG's Inventory Turnover Ratio PNTG's Growth Rates PNTG's Dividend Statistics
PNTG's Profitability Ratios PNTG's Asset Turnover Ratio PNTG's Dividend Growth
PNTG's Roe PNTG's Valuation Ratios PNTG's Financial Strength Ratios PNTG's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Universal Health Services Inc   12.43 %
Ufp Technologies Inc   12.12 %
Solventum Corporation  11.98 %
Ligand Pharmaceuticals Incorporated  11.93 %
Lifevantage Corp  11.84 %
Regeneron Pharmaceuticals Inc   11.83 %
Protagonist Therapeutics inc   11.66 %
Encompass Health Corporation  11.56 %
Embecta Corp   11.20 %
Lemaitre Vascular Inc   11.20 %
3m Company  11.16 %
Globus Medical Inc   11.01 %
National Healthcare Corp  10.91 %
Bioventus Inc   10.85 %
Infusystem Holdings Inc  10.53 %
Livanova Plc  10.40 %
Beone Medicines Ltd   10.32 %
Entrada Therapeutics Inc   10.15 %
Jazz Pharmaceuticals Plc  10.06 %
Prestige Consumer Healthcare Inc   10.06 %
Tactile Systems Technology Inc   10.02 %
Tenet Healthcare Corp  9.98 %
Nature s Sunshine Products inc   9.91 %
Boston Scientific Corporation  9.91 %
Align Technology inc   9.50 %
Pediatrix Medical Group Inc   9.18 %
Abbvie Inc   9.11 %
Ani Pharmaceuticals Inc  9.09 %
Viemed Healthcare Inc   8.97 %
Stryker Corp  8.80 %

Date modified: 2026-09-26T07:37:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.